JPRN-jRCT2080221101UnknownPhase 2
Early Phase II clinical study of AK150 for the treatment of knee osteoarthritis
ASAHI KASEI PHARMA CORPORATIO0 sitesStarted: May 18, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 50age old to <= 74age old (—)
- Sex
- All
Inclusion Criteria
- •(1)Ambulatory outpatients who do not need a cane or other orthopedic device to enable or assist in motility.
- •(2)Knee pain has experienced
- •(3)Patients should have a 2 - 3 on the Kellgren-Lawrence (K-L) grading scale by X-Ray.
Exclusion Criteria
- •(1) Having undergone some sort of surgical procedure or some other kind of invasive procedure in the evaluated knee.
- •(2) Secondary knee osteoarthritis in the evaluated knee.
- •(3) Intra-articular administration of hyaluronic acid to the evaluated knee within 3 months prior to the start of administration.
Investigators
Similar Trials
Unknown
Phase 3
Phase 3 clinical study of AK-120 in patients with herpes zosterHerpes zosterJPRN-jRCT2080220058ASAHIKASEI PHARMA CORPORATIO
Not yet recruiting
Phase 2
Phase II Clinical Trial: Efficacy and Safety of Kaempferia Parviflora in Treatment of Chronic Vertigo PatientsDizzinessKaempferia parviflora,chronic vertigo,Dizziness Handicap Inventory,Vestibular functionTCTR20181122001Agricultural Research Development Agency (Public Organization)72
Recruiting
Phase 2
Addition of consolidative radiation therapy to TKI versus TKI alone in driver mutated lung cancer patientsCTRI/2019/11/021872Tata Memorial Hospital
Unknown
Phase 2
A dose finding study of KRN125Chemotherapy-induced neutropeniaJPRN-jRCT2080220922Kyowa Hakko Kirin Co., Ltd.
Completed
Not Applicable
TRK-100STP Phase IIb/III Clinical Study Protocol?Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)?Endocrine, nutritional and metabolic diseaseKCT0000507Parexel750